Editing Amanita muscaria (section)

==== Recent rise in popularity ====
{{See also|Mushroom edible}}
As a result of a lack of regulation, the use of ''Amanita muscaria'' as a popular legal alternative to [[Hallucinogen|hallucinogens]] has grown exponentially in recent years. In 2024, [[Google Trends|Google]] searches for Amanita muscaria rose nearly 200% from the previous year, a trend that an article published in the [[American Journal of Preventive Medicine|American Journal of Preventative Medicine]] correlated with the sudden commercialization of ''Amanita muscaria'' products on the internet.<ref name="Leas-2024">{{Cite journal |last=Leas |first=Eric |date=June 10, 2024 |title=Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms |journal=[[American Journal of Preventive Medicine]]|volume=67 |issue=3 |pages=458–463 |doi=10.1016/j.amepre.2024.05.006 |pmid=38864780 |pmc=11832274 }}</ref>

While Amanita mushrooms are unscheduled in the United States, they are listed as a poison by the FDA.<ref>{{Cite book |title=Bad Bug Book |publisher=[[Food and Drug Administration]] |year=2012 |isbn=978-1973853237 |edition=2nd |location=United States |pages=222}}</ref> Amanita mushrooms and muscimol are not approved as an ingredient in food,<ref name=":0">{{Cite journal |last=Program |first=Human Foods |date=2024-12-18 |title=FDA Alerts Industry and Consumers about the Use of Amanita Muscaria or its Constituents in Food |url=https://www.fda.gov/food/hfp-constituent-updates/fda-alerts-industry-and-consumers-about-use-amanita-muscaria-or-its-constituents-food |journal=FDA |language=en}}</ref> with some drawing comparisons to the controversial legal status of [[Agriculture Improvement Act of 2018|hemp-derived cannabinoids]].<ref name="Leas-2024" /><ref>{{Cite web |last=Miller |first=Patricia |date=2024-01-25 |title=Can Brands Create Quality, Compliant Amanita Mushroom Products? |url=https://cannatechtoday.com/can-brands-create-quality-compliant-amanita-mushroom-products/ |access-date=2024-07-15 |website=Cannabis & Tech Today |language=en-US}}</ref> The FDA is currently evaluating the use of ''Amanita muscaria'' and its constituents in dietary supplements, reminding manufacturers to ensure their ingredients meet safety standards and encouraging them to consult the Office of Dietary Supplement Programs with any questions.<ref name="FDA2024b" />

A recent outbreak of poisonings and at least one death associated with products containing ''Amanita muscaria'' extracts has sparked debates regarding the [[Drug prohibition|regulatory status]] of Amanita mushrooms and their psychoactive constituents, prompting an FDA ban of their use in food products in December 2024.<ref name="Leas-2024" /><ref name="Blum-2024">{{Cite news |last=Blum |first=Dani |date=2024-06-10 |title=Mushroom Edibles Recalled After Spate of Serious Illnesses |url=https://www.nytimes.com/2024/06/10/fda-microdose-chocolate.html |access-date=2024-07-14 |work=The New York Times |language=en-US |issn=0362-4331}}</ref><ref name=":0" /> These products often use misleading advertising, such as erroneous comparisons to [[Psilocybin mushroom|Psilocybin mushrooms]] or simply not disclosing the inclusion of Amanita mushrooms on the packaging.<ref name="Blum-2024" /><ref>{{Cite web |last=Schuster-Bruce |first=Catherine |title=A legal psychedelic mushroom species is being sold in the US. It can cause euphoria — or 'temporary insanity' |url=https://www.businessinsider.com/legal-psychedelic-mushroom-amanita-muscaria-sold-us-euphoria-temporary-insanity-2022-10 |access-date=2024-07-14 |website=Business Insider |language=en-US}}</ref>